Droplet Digital PCR Assessment of MDM2 Amplification in Liposarcoma Diagnosis and Prognosis: A French Single-Center Cohort Study
International Journal of Molecular Sciences · 02.08.2026 · 27 (15) · 6932
DOI: 10.3390/ijms27156932 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 02.08.2026. Verfasst von Amira Amri und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Neuropathology, Timone Hospital, Assistance Publique-Hôpitaux de Marseille (AP-HM), Aix-Marseille University, 13005 Marse…. Hauptthemen laut MEDLINE: Liposarcoma, Proto-Oncogene Proteins c-mdm2, Gene Amplification, Polymerase Chain Reaction. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: aphm, Assistant Publique Hôpitaux de Marseille.
Abstract (Originalsprache)
Amplification of MDM2 is the molecular hallmark of atypical lipomatous tumor/well-differentiated liposarcoma (ALT/WDL) and dedifferentiated liposarcoma (DDL). While fluorescence in situ hybridization (FISH) is widely used for diagnosis, the diagnostic and prognostic value of droplet digital PCR (ddPCR) remains poorly defined. We retrospectively analyzed 341 primary adipocytic tumors, including 85 liposarcomas (22 DDL), using ddPCR to quantify MDM2 copy number variation (CNV). Diagnostic performance was compared with FISH, and associations with clinicopathological variables and outcomes were evaluated using non-parametric tests, ROC analysis, survival analysis, and Firth’s penalized Cox models. Comparison with FISH confirmed the diagnostic utility of ddPCR for detecting MDM2 amplification, while quantitative CNV assessment provided additional prognostic information. CNV values were significantly higher in deep-seated and dedifferentiated tumors and were strongly associated with local recurrence. ROC analysis identified a threshold of 16.85 copies predicting both dedifferentiation and recurrence (AUC 0.982 and 0.942, respectively). Patients with CNV ≥ 16.85 copies had significantly shorter recurrence-free and overall survival. In multivariable analysis, high CNV remained an independent predictor of recurrence (HR 36.6, 95% CI 4.0–4914.2). These findings support ddPCR as a robust method for MDM2 assessment and suggest that quantitative MDM2 copy number may improve both diagnosis and risk stratification in liposarcoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Neuropathology, Timone Hospital, Assistance Publique-Hôpitaux de Marseille (AP-HM), Aix-Marseille University, 13005 Marseille, France.
- Department of Medical Oncology, La Timone University Hospital, Assistance Publique-Hôpitaux de Marseille (AP-HM), 13005 Marseille, France.
- Orthopedic and Traumatologic Surgery Department, North Hospital, La Conception Hospital, Timone Hospital, Assistance Publique-Hôpitaux de Marseille (AP-HM), 13005 Marseille, France.
- Department of Radiology, La Conception University Hospital, Assistance Publique-Hôpitaux de Marseille (AP-HM), Aix-Marseille University, 13005 Marseille, France.
- EA 3279, CEReSS, Research Centre on Health Services and Quality of Life, Aix Marseille University, 13005 Marseille, France.
- Cell Biology Department, Timone Hospital, Institut National de la Santé et de la Recherche Médicale (INSERM), Marseille Medical Genetics (MMG), Assistance Publique-Hôpitaux de Marseille (AP-HM), Aix Marseille University…
ORCID-Profile: Romain Appay, Christophe Chagnaud, Ilyes Hamouda, Patrice Roll, Elise Kaspi, Diane Frankel
Förderung
- aphm
- Assistant Publique Hôpitaux de Marseille
Zitieren
APA
Amri, A., Haffner, A., Fina, F., Appay, R., Duffaud, F., Salas, S., Mattéi, J. C., Rochwerger, A., Chagnaud, C., Fernandez, R., Paula, A. M., Just, P. A., Hamouda, I., Diai, S., Neda, C. A., Roll, P., Kaspi, E., Gallardo, C., Barlier, A., …, & Macagno, N. (2026). Droplet Digital PCR Assessment of MDM2 Amplification in Liposarcoma Diagnosis and Prognosis: A French Single-Center Cohort Study. International Journal of Molecular Sciences, 27(15), 6932. https://doi.org/10.3390/ijms27156932
Vancouver
Amri A, Haffner A, Fina F, Appay R, Duffaud F, Salas S, et al. Droplet Digital PCR Assessment of MDM2 Amplification in Liposarcoma Diagnosis and Prognosis: A French Single-Center Cohort Study. International Journal of Molecular Sciences. 2026;27(15):6932. doi:10.3390/ijms27156932
BibTeX
@article{Amri2026,
author = {Amri, Amira and Haffner, Aurélie and Fina, Fréderic and Appay, Romain and Duffaud, Florence and Salas, Sébastien and Mattéi, Jean-Camille and Rochwerger, Alexandre and Chagnaud, Christophe and Fernandez, Rémi and Paula, André Maues de and Just, Pierre-Alexandre and Hamouda, Ilyes and Diai, Shani and Neda, Chelsea Anjuly and Roll, Patrice and Kaspi, Elise and Gallardo, Catherine and Barlier, Anne and Bouvier, Corinne and Frankel, Diane and Macagno, Nicolas},
title = {Droplet Digital PCR Assessment of MDM2 Amplification in Liposarcoma Diagnosis and Prognosis: A French Single-Center Cohort Study},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {15},
pages = {6932},
doi = {10.3390/ijms27156932}
}
EUVIMED